Matinas Biopharma (MTNB) Free Cash Flow (2017 - 2026)
Matinas Biopharma (MTNB) free cash flow from Sep 30, 2017 to Mar 31, 2026. The TTM Matinas Biopharma (MTNB) free cash flow is -$6.60M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Matinas Biopharma (MTNB) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -45.59% |
| 3 Years TTM | -29.51% |
| 5 Years TTM | -17.59% |
| All Time TTM | -2.93% |
Annual Free Cash Flow change of Matinas Biopharma (MTNB)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$1.60M | -77.18% |
| 2025 | -$7.01M | -55.86% |
| 2024 | -$16M | +2.45% |
| 2023 | -$16M | -22.69% |
| 2022 | -$20M | +29.52% |
| 2021 | -$15M | -10.93% |
| 2020 | -$17M | +19.86% |
| 2019 | -$15M | +33.52% |
| 2018 | -$11M | -12.42% |
| 2017 | -$12M | N/A |
Comparison Matinas Biopharma (MTNB) five years free cash flow CAGR with competitors
Matinas Biopharma (MTNB) five years free cash flow CAGR is -17.57%.